Brookdale Senior Living vs PACS
BKD and PACS side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BKD and PACS compare
PACS is the larger company, worth 3.5 times as much as Brookdale Senior Living ($7.7B against $2.2B).
PACS grew revenue faster over the last twelve months (15.2% versus −8.4% for Brookdale Senior Living).
PACS keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −1.3% at Brookdale Senior Living.
PACS scores higher on the StockData Score (12 against 6 for Brookdale Senior Living), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BKD | PACS |
|---|---|---|
| Size and price | ||
| Market cap | $2.2B | $7.7B |
| Share price | $9.17 | $48.32 |
| Change, 1 year | −12.7% | 322% |
| Change, 5 years | 37.9% | – |
| Beta (5Y) | 0.69 | 0.00 |
| Employees | 33K | 47K |
| StockData Score | ||
| Total score | 6 | 12 (better) |
| Valuation score | 2 (better) | 1 |
| Growth score | 1 | 4 (better) |
| Performance score | 2 | 4 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 27.6× |
| P/S | 0.7× (better) | 1.4× |
| P/B | – | 6.9× |
| EV/EBITDA | 12.3× (better) | 18.9× |
| P/FCF | 151× | – |
| PEG | – | 19.66 |
| FCF yield | 0.66% | – |
| Fair value | – | $40.54 |
| Margin of safety | – | −19.2% |
| Growth | ||
| Revenue growth (TTM) | −8.4% | 15.2% (better) |
| Revenue growth, 5Y average | −2.0% | – |
| Net income growth (TTM) | – | 104% |
| EPS growth (TTM) | – | 113% |
| Profitability | ||
| Gross margin | 27.6% (better) | 23.5% |
| Operating margin | 6.8% | 7.4% (better) |
| Net margin | −1.3% | 4.8% (better) |
| FCF margin | 0.49% | – |
| Return on equity | – | 28.1% |
| Return on invested capital | 4.0% | 29.4% (better) |
| Financial health | ||
| Debt / equity | – | 0.22 |
| Net debt / EBITDA | 7.95 | 0.20 (better) |
| Interest coverage | – | 13.9× |
| Current ratio | 1.05 (better) | 0.91 |
| Altman Z-score | −0.18 | 2.33 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 114% | 31.3% |
| Held by insiders | 1.4% | 78.5% |
| Insider net buying, 12 months | $358K (better) | −$119M |
| Short interest, % of float | 17.8% | 12.6% |
Go deeper
- BKD stock overview
- BKD income statement
- BKD valuation and score
- PACS stock overview
- PACS income statement
- PACS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.